Equity Details
Price & Market Data
Price: $609.2
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $42,549,108,736
Daily Volume: 0
Performance Metrics
1 Week: 0.87%
1 Month: -4.01%
3 Months: -9.38%
6 Months: -12.36%
1 Year: -10.41%
YTD: -12.33%
About Lonza Group AG (LZAGF)
Get current market data for Lonza Group AG (LZAGF). Price: 609.2, daily change: $0.00 / 0.00%. Market cap: 42,549,108,736. Performance YTD, 1-week, 3-month.
Company Details
Employees: 16866
Sector: Health technology
Industry: Biotechnology
Country: Switzerland
Details
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.